{"entity":{"id":"nct05788926","kind":"trial","name":"A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir)","aka":[],"tldr":"A phase 1 trial of TG6050 run by Transgene, terminated.","summary":"A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir) is a phase 1 interventional study registered as NCT05788926 by Transgene, with 22 participants enrolled, started 2023-04-05. Conditions recorded: Non-small Cell Lung Cancer. Interventions recorded: TG6050.","status":"historic","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT05788926","url":"https://clinicaltrials.gov/study/NCT05788926"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":["tg6050"],"companies":["transgene"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05788926","phase":"1","setting":"A Phase I Dose-escalation Trial of TG6050 Administered by Intravenous Infusion in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)","sponsor":"Transgene","enrolled":22,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05788926/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"drug":[{"id":"tg6050","kind":"drug","name":"TG6050","route":"/drugs/tg6050/"}],"company":[{"id":"transgene","kind":"company","name":"Transgene","route":"/companies/transgene/"}]}}